The Role of Inflammation and Leukocytes in the Pathogenesis of Sickle Cell Disease

References

• Pauling, L., Itano, H. A., Singer, S. J. and Wells, I. C. (1949). Sickle cell anemia, a molecular disease, Science, 110, 543–548.
   PubMed Web of Science ®Google Scholar
• Francis, R. B. and Johnson, C. S. (1991). Vascular occlusion in sickle cell disease: current concepts and unanswered questions, Blood, 77, 1405–1414.
   PubMed Web of Science ®Google Scholar
• Bunn, H. F. (1997). Pathogenesis and treatment of sickle cell disease, New England Journal of Medicine, 337, 762–769.
   PubMed Web of Science ®Google Scholar
• Ohene-Frempong, K., Weiner, S. J., Sleeper, L. A. et al. (1998). Cerebrovascular accidents in sickle cell disease: rates and risk factors, Blood, 91, 288–294.
   PubMed Web of Science ®Google Scholar
• Adams, R. J., Brambilla, D., McKie, V. C. et al. (1997). Stroke prevention in sickle cell disease (STOP): Baseline characterisitics of trial patients, Blood, 90, 123a (Abstract).
   Web of Science ®Google Scholar
• Platt, O. S., Branbilla, D. J., Rosse, W. J. et al. (1994). Mortality in sickle cell disease. Life expectancy and risk factors for early death, New England Journal of Medicine, 330, 1639–1644.
   PubMed Web of Science ®Google Scholar
• Platt, O. S. (2000). The acute chest syndrome of sickle cell disease, New England Journal of Medicine, 342, 1905–1907.
   Web of Science ®Google Scholar
• Hebbel, R. P. (1991). Beyond hemoglobin polymerization: the red cell membrane and sickle cell disease pathophysiology, Blood, 77, 214–237.
   PubMed Web of Science ®Google Scholar
• Swerlick, R. A., Eckman, J. R., Kumar, A., Jeittler, M. and Wick, T. M. (1993). α4β1-integrin expression of sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium, Blood, 82, 1891–1899.
   PubMed Web of Science ®Google Scholar
• Kumar, A., Eckman, J. R., Swerlick, R. A. and Wick, T. M. (1996). Phorbol ester stimulation increases sickle erythrocyte adherence to endothelium: a novel pathway involving α4β1 integrin receptors on sickle reticulocytes and fibronectin, Blood, 88, 4348–4358.
   PubMed Web of Science ®Google Scholar
• Hebbel, R. P. and Vercelloti, G. M. (1997). The endothelial biology of sickle cell disease, Journal of Laboratory and Clinical Medicine, 129, 288–293.
   PubMed Web of Science ®Google Scholar
• Hebbel, R. P., Schwartz, R. S. and Mohandas, N. (1985). The adhesive sickle erythrocyte: cause and consequence of abnormal interactions with endothelium, monocyte/macrophages and model membranes, Clinical Haematology, 14, 141–161.
   PubMedGoogle Scholar
• Brittain, H. A., Eckman, J. R., Swerlick, R. A., Howard, R. J. and Wick, T. M. (1993). Thrombospondin from activated platelets promotes sickle cell erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion, Blood, 81, 2137–2143.
   PubMed Web of Science ®Google Scholar
• Kumar, A., Eckman, J. R., Swerlick, R. A. and Wick, T. M. (1994). Sickle erythrocytes stimulated with phorbol ester adhere to endothelium via activated α4β1 integrin on sickle reticulocytes and fibronectin on endothelium, Blood, 84, 408 (Abstract).
   PubMed Web of Science ®Google Scholar
• Barabino, G. A., Wise, R. J., Woodbury, V. A. et al. (1997). Inhibition of sickle erythrocyte adhesion to immobilized thrombospondin by von Willebrand factor under dynamic flow conditions, Blood, 89, 2560–2567.
   PubMed Web of Science ®Google Scholar
• Joneckis, C. C., Ackley, R. L., Orringer, E. P., Wayner, E. A. and Parise, L. V. (1993). Integrin α4β1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia, Blood, 82, 3548–3555.
   PubMed Web of Science ®Google Scholar
• Joneckis, C. C., Shock, D. D., Cunningham, M. L., Orringer, E. P. and Parise, L. V. (1996). Glycoprotein IV-independent adhesion of sickle red blood cells to immobilized thrombspondin under flow conditions, Blood, 87, 4862–4870.
   PubMed Web of Science ®Google Scholar
• Udani, M. and Zen, Q. C. M. (1998). Basal cell adhesion molecule/lutheran protein. The receptor critical for sickle cell adhesion to laminin, Journal of Clinical Investigation, 101, 2550.
   PubMed Web of Science ®Google Scholar
• Kaul, D. K., Fabry, M. E. and Windsisch, P. (1983). Erythrocytes in sickle cell anemia are heterogeneous in their rheological and hemodynamic characteristics, Journal of Clinical Investigation, 72, 22–31.
   PubMed Web of Science ®Google Scholar
• Kaul, D. K., Tsai, H. M., Liu, X. D., Nakada, M. T., Nagel, R. L. and Coller, B. S. (2000). Monoclonal antibodies to αVβ3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor, Blood, 95, 368–374.
   PubMed Web of Science ®Google Scholar
• Natarajan, M., Udden, M. M. and McIntire, L. V. (1996). Adhesion of sickle red blood cells and damage to inter-leukin-1β stimulated endothelial cells under flow in vitro, Blood, 87, 4845–4852.
   PubMed Web of Science ®Google Scholar
• Solovey, A., Lin, Y., Browne, P., Choong, S. and Hebbel, R. P. (1997). Circulating endothelial cells in sickle cell anemia, New England Journal of Medicine, 337, 1584–1590.
   PubMed Web of Science ®Google Scholar
• Taylor, S. C., Shacks, S. J., Mitchell, R. A. and Banks, A. (1995). Serum interleukin-6 levels in the steady state of sickle cell disease, Journal of Interferon and Cytokine Research, 15, 1061–1064.
   PubMed Web of Science ®Google Scholar
• Francis, R. B. and Haywood, L. J. (1992). Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease, Journal of the National Medical Association, 84, 611–615.
   PubMed Web of Science ®Google Scholar
• Duits, A. J., Schnog, J., Lard, L., Saleh, A., Winkel, C. N. and Rojer, R. A. (1997). Elevated levels of IL-8 during sickle cell crisis, Blood, 90, 24b (Abstract).
   Web of Science ®Google Scholar
• Malave, I., Perdomo, Y., Escalona, E. et al. (1993). Levels of tumor necrosis factor alpha/cachectin (TNF alpha) in sera from patients with sickle cell disease, Acta Haematologica, 90, 172–176.
   PubMed Web of Science ®Google Scholar
• Singhal, A., Doherty, J. F., Raynes, J. G., McAdam, K. P., Thomas, P. W. and Serjeant, B. E. (1993). Is there an acute-phase response in steady-state sickle cell disease? Lancet, 341, 651–653.
   PubMed Web of Science ®Google Scholar
• Ballas, S. and Abboud, M. R. (1997). A Marker for tissue damage in patients with sickle cell disease, Proceedings of the National Sickle Cell Disease Conference, 186 (Abstract).
   Google Scholar
• Fadlon, E., Vordermeier, S., Pearson, T. C. et al. (1998). Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of disease show enhanced adhesion to vascular endothelium and increased expression of CD64, Blood, 91, 266–274.
   PubMed Web of Science ®Google Scholar
• Wun, T., Field, C., Welborn, J., Cheung, A. and Tablin, F. (1997). Thrombospondin (TSP) mediates the adhesion of sickle erythrocytes to platelets (PLT), Proceedings of the National Sickle Cell Disease Conference, (Abstract).
   Google Scholar
• Cermak, J., Key, N. S., Bach, R. R., Balla, J., Jacob, H. S. and Vercelloti, G. M. (1993). C-Reactive protein induces human peripheral blood monocytes to synthesize tissue factor, Blood, 82, 513–520.
   PubMed Web of Science ®Google Scholar
• Ridker, P. M., Glynn, R. J., Hennekens, C. H. (1998). C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk for first myocardial infarction, Circulation, 97, 2007–2011.
   PubMed Web of Science ®Google Scholar
• Furman, M. I., Benoit, S. E., Barnard, M. R. et al. (1998). Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease, Journal of the American College of Cardiology, 31, 352–358.
   PubMed Web of Science ®Google Scholar
• Griffin, T. G., McIntire, D. and Buchanan, G. R. (1994). High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease, New England Journal of Medicine, 330, 733–737.
   PubMed Web of Science ®Google Scholar
• Bernini, J. C., Rogers, Z. R., Sandler, R. S., Reisch, J. S., Quinn, C. T. and Buchanan, G. R. (1998). Beneficial effects of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease, Blood, 92, 3082–3089.
   PubMed Web of Science ®Google Scholar
• Gabay, C. and Kushner, I. (1999). Acute-phase proteins and other systemic responses to inflammation, New England Journal of Medicine, 340, 448–454.
   PubMed Web of Science ®Google Scholar
• West, M. S., Wethers, D., Smith, J. and Steinberg, M. (1992). Laboratory profile of sickle cell disease: a cross-sectional analysis. The Cooperative Study of Sickle Cell Disease, Journal of Clinical Epidemiology, 45, 893–909.
   PubMed Web of Science ®Google Scholar
• Peter, K., Nawroth, P., Conradt, C. et al. (1997). Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin, Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 505–512.
   PubMed Web of Science ®Google Scholar
• Miller, S. T., Sleeper, L. A., Pegelow, C. et al. (2000). Prediction of adverse outcomes in children with sickle cell disease, New England Journal of Medicine, 342, 83–89.
   PubMed Web of Science ®Google Scholar
• Balkaran, B., Char, G., Morris, J. S., Thomas, P. W., Serjeant, B. E. and Serjeant, G. R. (1992). Stroke in a cohort of patients with homozygous sickle cell disease, Journal of Pediatrics, 120, 360–366.
   PubMed Web of Science ®Google Scholar
• Hurlet-Jensen, A., Sano, M., Sheth, S., De Vivo, D. and Piomelli, S. (1997). Factors predictive of abnormal MRI in children with sickle cell disease, Proceedings of the National Sickle Cell Disease Conference, 100 (Abstract).
   Google Scholar
• Castro, O., Brambilla, D., Thorington, B. et al. (1994). The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease, Blood, 84, 643–649.
   PubMed Web of Science ®Google Scholar
• Ware, R. E., Schultz, W. H., O'Branski, E. E., Walkwe, A. R. and Kinney, T. R. (1997). Hydroxyurea and phlebotomy: an alternative therapy for stroke in children with sickle cell anemia, Proceedings of the National Sickle Cell Disease Conference, 99 (Abstract).
   Google Scholar
• Charache, S., Terrin, M. L., Moore, R. D. et al. (1995). Effect of hydroxyurea on the frequency of painful crisis in sickle cell anemia, New England Journal of Medicine, 332, 1317–1322.
   PubMed Web of Science ®Google Scholar
• Hofstra, T. C., Kalra, V. K., Meiselman, H. J. and Coates, T. D. (1996). Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate the neutrophil respiratory burst, Blood, 87, 4440–4447.
   PubMed Web of Science ®Google Scholar
• Hebbel, R. P. (1997). Perspective series: cell adhesion in vascular biology. Adhesive interactions of sickle erythrocytes with endothelium, Journal of Clinical Investigation, 99, 2561–2564.
   PubMed Web of Science ®Google Scholar
• Lachant, N. A. and Oseas, R. S. (1987). Vaso-occlusive crisis-associated neutrophil dysfunction in patients with sickle cell disease, American Journal of Medical Science, 294, 253–257.
   PubMed Web of Science ®Google Scholar
• Mollapour, E., Porter, J., Kaczmarski, R., Linch, D. C. and Roberts, P. J. (1998). Raised neutrophil phospholipase A2 activity and defective priming of NADPH oxidase and phospholipase A2 in sickle cell disease, Blood, 91, 3423–3429.
   PubMed Web of Science ®Google Scholar
• Styles, L., Schalkwijk, C. G., Aarsman, A. J., Vichinsky, E., Lubin, B. and Kuypers, F. (1996). Phospholipase A2 levels in acute chest syndrome of sickle cell disease, Blood, 87, 2573–2578.
   PubMed Web of Science ®Google Scholar
• Kasschau, M. R., Barabino, G. A., Bridges, K. R. and Golan, D. E. (1996). Adhesion of sickle neutrophils and erythrocytes to fibronectin, Blood, 87, 771–780.
   PubMed Web of Science ®Google Scholar
• Powars, D. R. (1994). Natural History of Disease: The First Two Decades. In Sickle Cell Disease: Basic Principles and Practice, edited by S. H. Embury, R. P. Hebbel, N. Mohandas, M. H. Steinberg, pp. 395–412, New York. Reven Press.
   Google Scholar
• Weyrich, A. S., Elstad, M. R., McEver, R. P. et al. (1996). Activated platelets signal chemokine synthesis by human monocytes, Journal of Clinical Investigation, 97, 1525–1534.
   PubMed Web of Science ®Google Scholar
• Mendoza, E., Gutgsell, N., Temple, J. D. and Issitt, P. (1991). Monocyte phagocytic activity in sickle cell disease, Acta Haematologica, 85, 199–201.
   PubMed Web of Science ®Google Scholar
• Gawaz, M., Fateh-Moghadan, S., Pilz, G., Gurland, H. J. and Werdan, K. (1995). Platelet activation and interaction with leukocytes in patients with sepsis and multiorgan failure, European Journal of Clinical Investigation, 25, 843–851.
   PubMed Web of Science ®Google Scholar
• Mickelson, J. K., Lakkis, N. M., Villareal-Levy, G., Hugh, B. J. and Smith, C. W. (1996). Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease? Journal of the American College of Cardiology, 28, 345–353.
   PubMed Web of Science ®Google Scholar
• Dias-Da-Motta, P. M., Arruda, V. R., Muscara, M. N. et al. (1996). The release of nitric oxide and superoxide anion by neutrophils and mononuclear cells from patients with sickle cell anemia, British Journal of Haematology, 93, 333–340.
   PubMed Web of Science ®Google Scholar
• Key, N. S., Slungaard, A., Dandelet, L. et al. (1998). Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease, Blood, 91, 4216–4223.
   PubMed Web of Science ®Google Scholar
• Francis, R. B. (1989). Elevated fibrin D-dimer fragment in sickle cell anemia: evidence for activation of coagulation during steady state as well as in painful crisis, Haemostasis, 19, 105–111.
   PubMedGoogle Scholar
• Kuypers, F. A., Styles, L., Yee, M., Schott, M. A., Lubin, B. H. and Vichinsky, E. (1995). Increased plasma levels of fragment 1.2 correlate with loss of phospholipid asymmetry in subpopulations of sickle cells, Blood, 86, 298 (Abstract).
   Web of Science ®Google Scholar
• Carson, S. D., Pirruccello, S. J. and Haire, W. D. (1990). Tissue factor antigen and activity are not expressed on the surface of intact cells isolated from an acute promyelocytic leukemia patient, Thrombosis Research, 59, 159–170.
   PubMed Web of Science ®Google Scholar
• Amirkhosravi, A., Alexander, M., May, K. et al. (1996). The importance of platelets in the expression of monocyte tissue factor antigen measured by a new whole blood flow cytometric assay, Thrombosis and Haemostasis, 75, 87–95.
   PubMed Web of Science ®Google Scholar
• Belcher, J. D., Marker, P. H., Weber, J., Hebbel, R. P. and Vercelloti, G. M. (1999). Upregulation of NF-κB, tissue factor, E-selectin, and neutrophil adhesion in endothelial cells incubated with monocytes and red blood cells from sickle cell anemia patients, Blood, 92, 496 (Abstract).
   Web of Science ®Google Scholar
• Wun, T., Paglieroni, T., Welborn, J. et al. (1997). Monocyte production of intracellular tumor necrosis factor-α (TNF-α) and Interleukin-1β (IL-1β) in peripheral blood monocytes from patients with sickle cell disease (SCD), Blood, 90, 26b (Abstract).
   Web of Science ®Google Scholar
• Wun, T., Paglieroni, T., Tablin, F., Welborn, J., Nelson, K. and Cheung, A. (1997). Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia, Journal of Laboratory and Clinical Medicine, 129, 507–516.
   PubMed Web of Science ®Google Scholar
• Wun, T., Paglieroni, T., Rangaswami, A. et al. (1998). Platelet activation in patient with sickle cell disease, British Journal of Haematology, 100, 741–749.
   PubMed Web of Science ®Google Scholar
• Kuranstin-Mills, J., Ibe, B. O., Raj, J. U., Siegel, R. S. and Lessin, L. S. (1994), Elevated urinary levels of thromboxane and prostacyclin meabolites in sickle cell disease reflects activated platelets in the circulation, British Journal of Haematology, 87, 580–585.
   PubMed Web of Science ®Google Scholar
• Tomer, A., Eckman, J. R. and Vroon, D. H. (1992). Platelet activation and procoagulant activity in sickle cell disease, Blood, 80, 11 (Abstract).
   Google Scholar
• Tomer, A., Harker, L. A. and Eckman, J. R. (1994). Circulating platelets and red cells promote in vivo thrombogenic activity in sickle cell disease, Blood, 84, 412 (Abstract).
   Web of Science ®Google Scholar
• Silverstein, R. L. and Nachman, R. L. (1987). Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion, Journal of Clinical Investigation, 79, 867–874.
   PubMed Web of Science ®Google Scholar
• Redlich, H., Vickers, J., Losche, W., Heptinstall, S., Kehrel, B. and Spangenberg, P. (1998). Formation of platelet-leukocyte conjugates in whole blood, Platelets, 8, 419–425.
   Web of Science ®Google Scholar
• Wun, T., Paglieroni, T., Rangaswami, A., Gosselin, R. and Cheung, A. T. (1999). Platelet-monocyte aggregates (PMA) in patients with sickle cell disease, Blood, 94, 198a (Abstract).
   Web of Science ®Google Scholar
• Sultana, C., Shen, Y., Rattan, V., Johnson, C. and Kalra, V. K. (1998). Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes, Blood, 10, 3924–3935.
   Google Scholar
• Powars, D. R., Meiselman, H. J., Fisher, T. C., Hiti, A. and Johnson, C. (1994). Beta-S gene cluster haplotypes modulate hematologic and hemorheologic expression in sickle cell anemia—Use in predicting clinical severity, The American Journal of Pediatric Hematology/Oncology, 16, 55–61.
   PubMedGoogle Scholar
• Powars, D. and Hiti, A. (1993). Sickle cell anemia—fgene cluster haplotypes as genetic markers for severe disease expression, American Journal of Diseases of Childhood, 147, 1197–1202.
   PubMedGoogle Scholar
• Powars, D., Chan, L. S. and Schroeder, W. A. (1990). The variable expression of sickle cell disease is genetically determined. Seminars in Hematology, 27, 360–367.
   PubMed Web of Science ®Google Scholar